Company Filing History:
Years Active: 1976
Title: Sven Erik Sjastrand: Innovator in Pharmaceutical Chemistry
Introduction
Sven Erik Sjastrand is a notable inventor based in Kungsbacka, Sweden. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that have therapeutic applications in treating heart diseases.
Latest Patents
Sjastrand holds a patent for "Phenoxy-hydroxypropylamines, their preparation, and method." This patent includes ortho-para-substituted phenoxy-hydroxypropylamines, which are characterized by their general formula and pharmaceutically acceptable, non-toxic acid addition salts. The compounds disclosed in this patent are designed to selectively block the .beta.-receptors of the heart, making them useful in treating heart diseases in both animals and humans. His innovative work has led to the preparation of pharmaceutical formulations that incorporate these newly discovered compounds.
Career Highlights
Sven Erik Sjastrand is associated with Aktiebolaget Hassle, where he has contributed to various research initiatives. His work has been instrumental in advancing the understanding of heart disease treatments through innovative chemical compounds. With a patent portfolio that includes 1 patent, Sjastrand has established himself as a key figure in pharmaceutical innovation.
Collaborations
Sjastrand has collaborated with notable colleagues, including Peder Bernhard Berntsson and Arne Elof Brandstrom. These collaborations have fostered a productive environment for research and development in the pharmaceutical sector.
Conclusion
Sven Erik Sjastrand's contributions to pharmaceutical chemistry highlight his role as an innovator in the field. His patented work on phenoxy-hydroxypropylamines showcases the potential for new treatments for heart diseases.